JP2015519346A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015519346A5 JP2015519346A5 JP2015514189A JP2015514189A JP2015519346A5 JP 2015519346 A5 JP2015519346 A5 JP 2015519346A5 JP 2015514189 A JP2015514189 A JP 2015514189A JP 2015514189 A JP2015514189 A JP 2015514189A JP 2015519346 A5 JP2015519346 A5 JP 2015519346A5
- Authority
- JP
- Japan
- Prior art keywords
- lipid nanoparticle
- nanoparticle composition
- lipid
- cancer
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261650729P | 2012-05-23 | 2012-05-23 | |
| US61/650,729 | 2012-05-23 | ||
| US201361784892P | 2013-03-14 | 2013-03-14 | |
| US61/784,892 | 2013-03-14 | ||
| PCT/US2013/042454 WO2013177415A1 (en) | 2012-05-23 | 2013-05-23 | Lipid nanoparticle compositions for antisense oligonucleotides delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017191221A Division JP2018002727A (ja) | 2012-05-23 | 2017-09-29 | アンチセンスオリゴヌクレオチドを送達するための脂質ナノ粒子組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015519346A JP2015519346A (ja) | 2015-07-09 |
| JP2015519346A5 true JP2015519346A5 (enExample) | 2016-07-14 |
| JP6220389B2 JP6220389B2 (ja) | 2017-10-25 |
Family
ID=48539454
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015514192A Pending JP2015525209A (ja) | 2012-05-23 | 2013-05-23 | 脂質ナノ粒子組成物と、それを作製する方法、及びそれを使用する方法 |
| JP2015514189A Expired - Fee Related JP6220389B2 (ja) | 2012-05-23 | 2013-05-23 | アンチセンスオリゴヌクレオチドを送達するための脂質ナノ粒子組成物 |
| JP2015514193A Active JP6228191B2 (ja) | 2012-05-23 | 2013-05-23 | 脂質コートされたアルブミンナノ粒子組成物と、それを作製する方法、及びそれを使用する方法 |
| JP2017191221A Pending JP2018002727A (ja) | 2012-05-23 | 2017-09-29 | アンチセンスオリゴヌクレオチドを送達するための脂質ナノ粒子組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015514192A Pending JP2015525209A (ja) | 2012-05-23 | 2013-05-23 | 脂質ナノ粒子組成物と、それを作製する方法、及びそれを使用する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015514193A Active JP6228191B2 (ja) | 2012-05-23 | 2013-05-23 | 脂質コートされたアルブミンナノ粒子組成物と、それを作製する方法、及びそれを使用する方法 |
| JP2017191221A Pending JP2018002727A (ja) | 2012-05-23 | 2017-09-29 | アンチセンスオリゴヌクレオチドを送達するための脂質ナノ粒子組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US10307490B2 (enExample) |
| EP (3) | EP2852380A4 (enExample) |
| JP (4) | JP2015525209A (enExample) |
| KR (3) | KR20150032945A (enExample) |
| CN (3) | CN104428005B (enExample) |
| AU (4) | AU2013266238B2 (enExample) |
| BR (2) | BR112014027834A2 (enExample) |
| CA (3) | CA2871477A1 (enExample) |
| MX (3) | MX353567B (enExample) |
| WO (3) | WO2013177415A1 (enExample) |
Families Citing this family (111)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8986702B2 (en) | 2008-05-16 | 2015-03-24 | Taiga Biotechnologies, Inc. | Antibodies and processes for preparing the same |
| DK2966084T3 (en) | 2008-08-28 | 2018-08-06 | Taiga Biotechnologies Inc | MODULATORS OF MYC, PROCEDURES FOR USING SAME AND PROCEDURES FOR IDENTIFYING SUBSTANCES MODULATING MYC |
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| ES3005233T3 (en) | 2010-10-01 | 2025-03-14 | Modernatx Inc | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| JP2014511687A (ja) | 2011-03-31 | 2014-05-19 | モデルナ セラピューティクス インコーポレイテッド | 工学操作された核酸の送達および製剤 |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP2763701B1 (en) | 2011-10-03 | 2018-12-19 | Moderna Therapeutics, Inc. | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| JP2015501844A (ja) | 2011-12-16 | 2015-01-19 | モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | 修飾ヌクレオシド、ヌクレオチドおよび核酸組成物 |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US9254311B2 (en) | 2012-04-02 | 2016-02-09 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins |
| WO2013151663A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of membrane proteins |
| AU2013266238B2 (en) | 2012-05-23 | 2017-07-27 | The Ohio State University | Lipid-coated albumin nanoparticle compositions and methods of making and method of using the same |
| AU2013292330B2 (en) | 2012-07-20 | 2018-07-12 | Htyr Acquisition Llc | Enhanced reconstitution and autoreconstitution of the hematopoietic compartment |
| ES2921623T3 (es) | 2012-11-26 | 2022-08-30 | Modernatx Inc | ARN modificado terminalmente |
| US10272115B2 (en) | 2013-03-11 | 2019-04-30 | Taiga Biotechnologies, Inc. | Production and use of red blood cells |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| HUE040425T2 (hu) | 2013-04-30 | 2019-03-28 | Delta Fly Pharma Inc | Liposzóma topikális adagoláshoz és alkalmazása |
| US9802967B2 (en) * | 2013-06-17 | 2017-10-31 | The University Of North Carolina At Chapel Hill | Polymer coated particles and methods thereof |
| KR20160042917A (ko) | 2013-07-25 | 2016-04-20 | 엑시큐어, 인크. | 예방 및 치료 용도를 위한 면역자극제로서의 구형 핵산-기재 구축물 |
| WO2015048744A2 (en) | 2013-09-30 | 2015-04-02 | Moderna Therapeutics, Inc. | Polynucleotides encoding immune modulating polypeptides |
| KR20160067219A (ko) | 2013-10-03 | 2016-06-13 | 모더나 세라퓨틱스, 인코포레이티드 | 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드 |
| WO2015130584A2 (en) * | 2014-02-25 | 2015-09-03 | Merck Sharp & Dohme Corp. | Lipid nanoparticle vaccine adjuvants and antigen delivery systems |
| WO2015154002A1 (en) * | 2014-04-04 | 2015-10-08 | Ohio State Innovation Foundation | Oligonucleotide lipid nanoparticle compositions, methods of making and methods of using the same |
| WO2015175965A1 (en) | 2014-05-15 | 2015-11-19 | The Research Foundation For Suny | Compositions targeting the interaction domain between p27kip1 and brk and methods of use thereof |
| EP3164113B1 (en) | 2014-06-04 | 2019-03-27 | Exicure, Inc. | Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications |
| WO2016028940A1 (en) | 2014-08-19 | 2016-02-25 | Northwestern University | Protein/oligonucleotide core-shell nanoparticle therapeutics |
| WO2016068160A1 (ja) * | 2014-10-30 | 2016-05-06 | Ｄｅｌｔａ－Ｆｌｙ Ｐｈａｒｍａ株式会社 | 局所投与用リポプレックスの新規製造方法及び該リポプレックスを使用する抗腫瘍剤 |
| US11213593B2 (en) | 2014-11-21 | 2022-01-04 | Northwestern University | Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates |
| KR20170104550A (ko) * | 2015-01-14 | 2017-09-15 | 엑시큐어, 인크. | 코어 모티프를 갖는 핵산 나노구조 |
| WO2016160822A1 (en) * | 2015-03-30 | 2016-10-06 | Verily Life Sciences Llc | Functionalized nanoparticles, methods and in vivo diagnostic system |
| EP3283059B1 (en) | 2015-04-13 | 2024-01-03 | CureVac Manufacturing GmbH | Method for producing rna compositions |
| WO2016197024A2 (en) * | 2015-06-05 | 2016-12-08 | MiRagen Therapeutics, Inc. | Mir-155 inhibitors for treating cutaneous t cell lymphoma (ctcl) |
| RS63030B1 (sr) | 2015-09-17 | 2022-04-29 | Modernatx Inc | Jedinjenja i kompozicije za intracelularno isporučivanje terapeutskih sredstava |
| CN105288647B (zh) * | 2015-10-10 | 2018-05-25 | 中国药科大学 | 功能化白蛋白及其纳米制剂的制备方法 |
| CA3007955A1 (en) * | 2015-12-10 | 2017-06-15 | Modernatx, Inc. | Lipid nanoparticles for delivery of therapeutic agents |
| JP7114465B2 (ja) | 2015-12-22 | 2022-08-08 | モデルナティエックス インコーポレイテッド | 薬剤の細胞内送達のための化合物および組成物 |
| US11364304B2 (en) | 2016-08-25 | 2022-06-21 | Northwestern University | Crosslinked micellar spherical nucleic acids |
| CN107951862B (zh) * | 2016-10-17 | 2021-03-12 | 南京绿叶制药有限公司 | 一种抑制bcl-2的反义寡聚核酸的脂质纳米粒及其制备方法 |
| US12491261B2 (en) | 2016-10-26 | 2025-12-09 | Acuitas Therapeutics, Inc. | Lipid nanoparticle formulations |
| US11583504B2 (en) | 2016-11-08 | 2023-02-21 | Modernatx, Inc. | Stabilized formulations of lipid nanoparticles |
| CN113786476A (zh) * | 2016-12-02 | 2021-12-14 | 泰加生物工艺学公司 | 纳米颗粒调配物 |
| US12564558B2 (en) | 2016-12-09 | 2026-03-03 | Board Of Regents, The University Of Texas System | Hybrid exosomal-polymeric (hexpo) nano-platform for delivery of RNAi therapeutics |
| EP3554535A4 (en) | 2016-12-14 | 2020-10-21 | Janssen Biotech, Inc. | PD-L1 BINDING FIBRONECTIN TYPE III DOMAINS |
| BR112019012154A2 (pt) | 2016-12-14 | 2019-11-12 | Janssen Biotech, Inc. | domínios do tipo iii da fibronectina de ligação a cd8a |
| EP3554561B1 (en) | 2016-12-14 | 2023-06-28 | Janssen Biotech, Inc. | Cd137 binding fibronectin type iii domains |
| US20180179577A1 (en) * | 2016-12-22 | 2018-06-28 | Jiaming HU | Lipid-polymer Hybrid Nanoparticle Biochip and Application Thereof |
| EP3558407B1 (en) * | 2016-12-22 | 2023-03-15 | Biotronik AG | Drug releasing coatings for medical devices and methods of making same |
| KR101916941B1 (ko) * | 2016-12-30 | 2018-11-08 | 주식회사 삼양바이오팜 | 플라스미드 디엔에이 전달용 고분자 나노입자 조성물 및 그의 제조방법 |
| CA3056133A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Crystal forms of amino lipids |
| KR20190132405A (ko) | 2017-03-15 | 2019-11-27 | 모더나티엑스, 인크. | 치료제의 세포내 전달을 위한 화합물 및 조성물 |
| ES3020935T3 (en) | 2017-03-15 | 2025-05-23 | Modernatx Inc | Lipid nanoparticle formulation |
| WO2018187590A1 (en) | 2017-04-05 | 2018-10-11 | Modernatx, Inc. | Reduction or elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins |
| US11696954B2 (en) | 2017-04-28 | 2023-07-11 | Exicure Operating Company | Synthesis of spherical nucleic acids using lipophilic moieties |
| WO2018209270A1 (en) | 2017-05-11 | 2018-11-15 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (snas) |
| CN107184552B (zh) * | 2017-06-07 | 2021-03-30 | 东华大学 | 一种半乳糖化聚乙烯亚胺修饰的载药醇质体的制备方法 |
| US12077501B2 (en) | 2017-06-14 | 2024-09-03 | Modernatx, Inc. | Compounds and compositions for intracellular delivery of agents |
| WO2018232357A1 (en) | 2017-06-15 | 2018-12-20 | Modernatx, Inc. | Rna formulations |
| JP7231147B2 (ja) * | 2017-06-29 | 2023-03-01 | 国立大学法人東海国立大学機構 | Ｒｎａ導入試薬及びその利用 |
| EP3655776B1 (en) * | 2017-07-18 | 2026-03-25 | Avectas Limited | Payload delivery across cell membranes using continuous flow fluidic system |
| US10149898B2 (en) | 2017-08-03 | 2018-12-11 | Taiga Biotechnologies, Inc. | Methods and compositions for the treatment of melanoma |
| EP4328314A3 (en) * | 2017-08-22 | 2024-03-20 | Tessera Therapeutics, Inc. | Lipid nanoparticle methods and compositions for producing engineered erythroid cells |
| WO2019046809A1 (en) | 2017-08-31 | 2019-03-07 | Modernatx, Inc. | METHODS OF MANUFACTURING LIPID NANOPARTICLES |
| CN107982537A (zh) * | 2017-11-17 | 2018-05-04 | 厦门大学 | 针对microRNA-155的治疗性药物及其应用 |
| KR102245539B1 (ko) * | 2018-02-12 | 2021-04-29 | 주식회사 지앤피바이오사이언스 | 코어-쉘 구조의 마이크로 입자를 유효성분으로 포함하는 성장인자 유전자 발현 증가용 조성물 |
| EP3789043A4 (en) * | 2018-03-29 | 2022-08-03 | Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences | Extraction of plant source "medicinal soup" and manual preparation of "herbal medicine" and related products |
| EP3784252A4 (en) * | 2018-04-18 | 2022-03-16 | Oisin Biotechnologies, Inc. | FUSOGENIC LIPID DNANOPARTICLES AND METHODS FOR THEIR PRODUCTION AND USE IN TARGET CELL SPECIFIC MANUFACTURE OF A THERAPEUTIC PROTEIN AND TREATMENT OF A TARGET CELL RELATED DISEASE, CONDITION OR DISORDER |
| JP7600099B2 (ja) * | 2018-05-15 | 2024-12-16 | フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー | 有害生物防除組成物及びその使用 |
| US10987428B2 (en) * | 2018-06-01 | 2021-04-27 | City Of Hope | Phosphorothioate-conjugated miRNAs and methods of using the same |
| WO2019231051A1 (ko) * | 2018-06-01 | 2019-12-05 | 서강대학교 산학협력단 | 지질을 이용한 표면 개질을 통해 세포 내 섭취 효율을 향상시킨 나노입자 복합체 및 이의 제조방법 |
| CN108743962B (zh) * | 2018-06-19 | 2021-07-02 | 东华大学 | 一种基于荧光碳点修饰的树状大分子的双载药靶向纳米平台的制备方法 |
| US12357580B2 (en) | 2018-06-19 | 2025-07-15 | The Board Of Regents Of The University Of Texas System | Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids |
| EP3846822A4 (en) * | 2018-09-04 | 2022-07-06 | The Board Of Regents Of The University Of Texas System | COMPOSITIONS AND METHODS FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACIDS |
| GB2592504B (en) * | 2018-09-04 | 2023-02-15 | Univ Texas | Compositions and methods for organ specific delivery of nucleic acids |
| WO2020061367A1 (en) | 2018-09-19 | 2020-03-26 | Modernatx, Inc. | Compounds and compositions for intracellular delivery of therapeutic agents |
| WO2020061457A1 (en) | 2018-09-20 | 2020-03-26 | Modernatx, Inc. | Preparation of lipid nanoparticles and methods of administration thereof |
| US12583816B2 (en) | 2018-10-18 | 2026-03-24 | Acuitas Therapeutics, Inc. | Lipids for lipid nanoparticle delivery of active agents |
| TW202028222A (zh) | 2018-11-14 | 2020-08-01 | 美商Ionis製藥公司 | Foxp3表現之調節劑 |
| AU2020204989A1 (en) * | 2019-01-04 | 2021-07-08 | Elevatebio Technologies, Inc. | Encapsulated RNA polynucleotides and methods of use |
| CN113874033A (zh) | 2019-04-08 | 2021-12-31 | 泰加生物工艺学公司 | 用于冷冻保存免疫细胞的组合物和方法 |
| JP2022532608A (ja) | 2019-05-14 | 2022-07-15 | タイガ バイオテクノロジーズ，インク． | Ｔ細胞疲弊を処置するための組成物および方法 |
| CA3155015A1 (en) | 2019-09-19 | 2021-03-25 | Modernatx, Inc. | Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents |
| MX2022003269A (es) | 2019-09-19 | 2022-07-04 | Modernatx Inc | Compuestos lipidicos de cola ramificada y composiciones para la administracion intracelular de agentes terapeuticos. |
| WO2021076546A1 (en) | 2019-10-14 | 2021-04-22 | Aro Biotherapeutics Company | Cd71 binding fibronectin type iii domains |
| US11781138B2 (en) | 2019-10-14 | 2023-10-10 | Aro Biotherapeutics Company | FN3 domain-siRNA conjugates and uses thereof |
| US12491255B2 (en) | 2019-10-14 | 2025-12-09 | Aro Biotherapeutics Company | EPCAM binding fibronectin type III domains |
| CN115778904B (zh) * | 2019-10-29 | 2025-03-28 | 珠海丽凡达生物技术有限公司 | 一种用于体外转染和体内递送mRNA的制剂 |
| KR102198736B1 (ko) | 2020-01-15 | 2021-01-05 | 이화여자대학교 산학협력단 | 생체 내 약물 전달을 위한 지질 나노입자 및 이의 용도 |
| CA3170142A1 (en) * | 2020-02-19 | 2021-08-26 | Nammi Therapeutics, Inc. | Formulated and/or co-formulated liposome compositions containing tfgb antagonist prodrugs useful in the treatment of cancer and methods thereof |
| JP7798855B2 (ja) | 2020-07-16 | 2026-01-14 | アクイタス セラピューティクス インコーポレイテッド | 脂質ナノ粒子に使用するためのカチオン性脂質 |
| CN116171150A (zh) | 2020-08-14 | 2023-05-26 | 阿克丘勒斯治疗公司 | 冻干脂质纳米颗粒的方法 |
| WO2022192674A1 (en) * | 2021-03-11 | 2022-09-15 | The Trustees Of The University Of Pennsylvania | Targeted therapeutic lipid nanoparticles and methods of use |
| US12239710B2 (en) | 2021-04-14 | 2025-03-04 | Aro Biotherapeutics Company | FN3 domain-siRNA conjugates and uses thereof |
| IL307582A (en) | 2021-04-14 | 2023-12-01 | Aro Biotherapeutics Company | CD71-binding domains of the fibronectin type |
| KR20240004540A (ko) | 2021-04-20 | 2024-01-11 | 비온드 바이오로직스 엘티디 | 세포내 전달 조성물 |
| WO2023070132A1 (en) * | 2021-10-22 | 2023-04-27 | Ohio State Innovation Foundation | Immunotherapies for the treatment of cancer |
| EP4426357A1 (en) * | 2021-11-03 | 2024-09-11 | Biond Biologics Ltd. | Intracellular delivery compositions |
| CA3242402A1 (en) | 2021-12-16 | 2023-06-22 | Acuitas Therapeutics, Inc. | Lipids for use in lipid nanoparticle formulations |
| CN114306369B (zh) * | 2021-12-23 | 2023-12-26 | 北京悦康科创医药科技股份有限公司 | 一种硫代寡核苷酸注射液及其制备方法 |
| US20250312430A1 (en) * | 2022-03-30 | 2025-10-09 | The Johns Hopkins University | Compositions of lipid nanoparticles for plasmid dna delivery to the liver and methods for preparing the same |
| AU2023329918A1 (en) * | 2022-08-25 | 2025-04-10 | Ohio State Innovation Foundation | Compositions and methods for the delivery of active agents including nucleic acids |
| US20260069713A1 (en) * | 2022-08-29 | 2026-03-12 | Vivasor, Inc. | Lipid-Coated Nanoparticles |
| WO2024136219A1 (ko) * | 2022-12-19 | 2024-06-27 | 주식회사 포스테라헬스사이언스 | 나노 입자를 포함하는 흡입 제형 및 이의 제조 방법 |
| EP4688003A2 (en) * | 2023-03-31 | 2026-02-11 | The Whiteoak Group, Inc. | Liposomal compositions of archexin |
| WO2025034965A1 (en) * | 2023-08-09 | 2025-02-13 | Board Of Regents, The University Of Texas System | Targeted therapeutic delivery of lipid nanoparticles |
| WO2025036297A1 (zh) | 2023-08-11 | 2025-02-20 | 浙江海昶生物医药技术有限公司 | 一种具有靶向性的脂质组合物及其制备方法 |
| TWI880568B (zh) * | 2024-01-04 | 2025-04-11 | 訊聯生物科技股份有限公司 | 包含生物巨分子及奈米載體之組合物、包含其的醫藥組成物及其用途 |
| WO2025171027A1 (en) * | 2024-02-05 | 2025-08-14 | University Of Rhode Island Board Of Trustees | Phlip ®-lnp for targeted intracellular delivery of nucleic acid therapeutics |
| US12553050B2 (en) | 2024-03-22 | 2026-02-17 | Takeda Pharmaceutical Company Limited | Compositions and methods for inhibiting cytochrome P450 family 7 subfamily a member 1 (CYP7A1) expression |
| WO2025221397A1 (en) * | 2024-04-17 | 2025-10-23 | University Of Connecticut | Albumin nanoparticles for efficient vaccine delivery |
| KR20250157196A (ko) * | 2024-04-26 | 2025-11-04 | 한국과학기술원 | 핵산 분자의 흡입 전달용 지질 나노복합체 |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US590877A (en) * | 1897-09-28 | Danger-signal for railway-crossings | ||
| US2003203A (en) * | 1933-05-15 | 1935-05-28 | Kim Young Wo | Game |
| US5725871A (en) | 1989-08-18 | 1998-03-10 | Danbiosyst Uk Limited | Drug delivery compositions comprising lysophosphoglycerolipid |
| US5707644A (en) | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery |
| US5466468A (en) | 1990-04-03 | 1995-11-14 | Ciba-Geigy Corporation | Parenterally administrable liposome formulation comprising synthetic lipids |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| US5756353A (en) | 1991-12-17 | 1998-05-26 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol-and liposome-based delivery |
| ES2105262T3 (es) | 1992-05-18 | 1997-10-16 | Minnesota Mining & Mfg | Dispositivo de suministro de farmaco a traves de las mucosas. |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| IE80468B1 (en) | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
| US20020022264A1 (en) * | 1995-05-26 | 2002-02-21 | Sullivan Sean M. | Delivery vehicles comprising stable lipid/nucleic acid complexes |
| US5908777A (en) * | 1995-06-23 | 1999-06-01 | University Of Pittsburgh | Lipidic vector for nucleic acid delivery |
| US6248720B1 (en) * | 1996-07-03 | 2001-06-19 | Brown University Research Foundation | Method for gene therapy using nucleic acid loaded polymeric microparticles |
| US6056973A (en) * | 1996-10-11 | 2000-05-02 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method of preparation |
| ES2212305T3 (es) | 1997-06-23 | 2004-07-16 | Alza Corporation | Polinucleotidos encapsulados en liposomas, composicion y procedimiento. |
| US6395253B2 (en) * | 1998-04-23 | 2002-05-28 | The Regents Of The University Of Michigan | Microspheres containing condensed polyanionic bioactive agents and methods for their production |
| EP1189611B1 (en) * | 1999-06-14 | 2006-05-03 | Cancer Research Technology Limited | Cancer therapy |
| CN100368020C (zh) * | 1999-08-27 | 2008-02-13 | 不列颠哥伦比亚大学 | 用于刺激细胞因子分泌和诱导免疫应答的组合物 |
| US7060291B1 (en) | 1999-11-24 | 2006-06-13 | Transave, Inc. | Modular targeted liposomal delivery system |
| WO2001076643A1 (en) | 2000-04-07 | 2001-10-18 | Baylor College Of Medicine | Macroaggregated protein conjugates as oral genetic immunization delivery agents |
| US6613308B2 (en) | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
| AU2002256398A2 (en) * | 2001-04-30 | 2002-11-11 | Targeted Genetics Corporation | Lipid-comprising drug delivery complexes and methods for their production |
| CA2449054C (en) * | 2001-05-30 | 2011-01-04 | The Scripps Research Institute | Integrin targeting liposome for nucleic acid delivery |
| JP2003088371A (ja) * | 2001-09-04 | 2003-03-25 | Mitsubishi Pharma Corp | 遺伝子導入用組成物 |
| KR100484371B1 (ko) | 2001-10-25 | 2005-04-20 | 가부시키가이샤 아텍스 | 히터선부착 시트체의 제조방법 |
| EP1441763A2 (en) * | 2001-11-07 | 2004-08-04 | Inex Pharmaceuticals Corp. | Mucosal adjuvants comprising an oligonucleotide and a cationic lipid |
| US7678386B2 (en) | 2002-07-15 | 2010-03-16 | Board Of Regents The University Of Texas | Liposomes coated with selected antibodies that bind to aminophospholipids |
| AU2003258183B2 (en) * | 2002-08-16 | 2009-03-26 | Rexahn Pharmaceuticals, Inc. | Use of antisense oligonucleotides to inhibit the expression of Akt-1 |
| WO2004064731A2 (en) | 2003-01-14 | 2004-08-05 | University Of Washington | Lipid-drug formulations and methods for targeted delivery of lipid-drug complexes to lymlplhoid tissues |
| JP4546454B2 (ja) | 2003-01-28 | 2010-09-15 | レクサーン・コーポレイション | Ｈｉｆ−１発現を抑制するアンチセンスオリゴヌクレオチド |
| ATE441710T1 (de) | 2003-01-31 | 2009-09-15 | Rexahn Corp | Antisense oligonukleotide, die die ausprägungsstufe von hif-1 hemmen |
| CN1882693B (zh) * | 2003-09-15 | 2012-08-15 | 普洛体维生物治疗公司 | 聚乙二醇修饰的脂质化合物及其应用 |
| KR100638041B1 (ko) | 2003-12-24 | 2006-10-23 | 주식회사 삼양사 | 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법 |
| JP2006111591A (ja) * | 2004-10-15 | 2006-04-27 | Anges Mg Inc | 核酸医薬を標的特異的に細胞内送達するための製剤 |
| JP2006298780A (ja) * | 2005-04-15 | 2006-11-02 | Tohoku Univ | Ｈｇｆ遺伝子と粗大凝集アルブミン−ポリエチレンイミン（ｍａａ−ｐｅｉ）との複合体 |
| US20070087045A1 (en) * | 2005-10-14 | 2007-04-19 | Industrial Technology Research Institute | Lipid carrier and method of preparing the same |
| TW200800235A (en) * | 2005-10-18 | 2008-01-01 | Otsuka Pharma Co Ltd | Carrier composition for nucleic acid transport |
| WO2007051303A1 (en) * | 2005-11-02 | 2007-05-10 | Protiva Biotherapeutics, Inc. | MODIFIED siRNA MOLECULES AND USES THEREOF |
| US8067380B2 (en) | 2005-12-19 | 2011-11-29 | Industrial Technology Research Institute | Glutathione-based delivery system |
| GB2450475A (en) * | 2007-06-12 | 2008-12-31 | Univ Nottingham Trent | Antimicrobial polymer nanocomposite |
| US20110177155A1 (en) * | 2007-08-21 | 2011-07-21 | Immune Disease Institute, Inc. | Methods of delivery of agents to leukocytes and endothelial cells |
| PL208054B1 (pl) * | 2007-09-06 | 2011-03-31 | Akademia Medyczna Im Piastow Śląskich We Wrocławiu | Kompozycja lipidowa do wytwarzania lipidowego nośnika dla leków genetycznych i jej zastosowanie |
| KR101198354B1 (ko) * | 2007-10-17 | 2013-03-14 | 주식회사 삼양바이오팜 | 핵산 전달용 저밀도 지단백질 유사(ＬＤＬ-ｌｉｋｅ) 양이온성 나노입자, 그의 제조방법 및 이를 이용한 핵산의 전달 방법 |
| BRPI0820302A2 (pt) * | 2007-11-09 | 2015-05-19 | Univ Northeastern | Nanopartículas semelhantes a micelas de automontagem para liberação sistêmica de gene |
| EP2222851B1 (en) * | 2007-11-20 | 2017-06-28 | Ionis Pharmaceuticals, Inc. | Modulation of cd40 expression |
| CA2710983A1 (en) * | 2007-12-27 | 2009-10-01 | The Ohio State University Research Foundation | Lipid nanoparticle compositions and methods of making and using the same |
| WO2009123734A1 (en) | 2008-04-04 | 2009-10-08 | The Regents Of The University Of California | Functionalized magnetic nanoparticles and methods of use thereof |
| US8222220B2 (en) | 2008-05-13 | 2012-07-17 | George Mason Intellectual Properties, Inc. | Nanogenomics for medicine: siRNA engineering |
| US8389768B2 (en) * | 2008-05-19 | 2013-03-05 | The University Of North Carolina At Chapel Hill | Methods and compositions comprising novel cationic lipids |
| US20090312402A1 (en) * | 2008-05-20 | 2009-12-17 | Contag Christopher H | Encapsulated nanoparticles for drug delivery |
| CA2732229C (en) * | 2008-07-25 | 2023-10-17 | Alnylam Pharmaceuticals, Inc. | Enhancement of sirna silencing activity using universal bases or mismatches in the sense strand |
| WO2010014595A2 (en) | 2008-07-31 | 2010-02-04 | The Ohio State University Research Foundation | Methods and compositions for delivering therapeutic agents in the treatment of b-cell related disorders |
| EP2366386A4 (en) * | 2008-10-28 | 2013-11-27 | Univ Santiago Compostela | NANOTEHTIC SYSTEMS MANUFACTURED FROM ANIONIC POLYMERS |
| US8722082B2 (en) * | 2008-11-10 | 2014-05-13 | Tekmira Pharmaceuticals Corporation | Lipids and compositions for the delivery of therapeutics |
| EP2601934A1 (en) | 2009-01-22 | 2013-06-12 | Ludwig-Maximilians-Universität München | Vesicular phospholipid gels comprising proteinaceous substances |
| ES2351756B1 (es) | 2009-07-28 | 2011-10-05 | Universidad Del Pais Vasco | Nanopartículas lipídicas para terapia génica. |
| EP2504452A4 (en) * | 2009-11-23 | 2014-06-11 | Univ Ohio State Res Found | MATERIALS AND METHODS FOR INFLUENCING GROWTH, MIGRATION AND INVASION OF TUMOR CELLS |
| AU2011232669B2 (en) * | 2010-03-26 | 2016-08-25 | The Ohio State University | Materials and methods related to modulation of mismatch repair and genomic stability by miR-155 |
| EP2553019A1 (en) * | 2010-03-26 | 2013-02-06 | Mersana Therapeutics, Inc. | Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof |
| EP2561072A4 (en) | 2010-04-20 | 2016-04-06 | Univ Florida | NANOZYME, METHOD FOR THE PRODUCTION OF NANOCYMENTS AND METHOD FOR THE USE OF NANOCYMENTS |
| US20130260460A1 (en) * | 2010-04-22 | 2013-10-03 | Isis Pharmaceuticals Inc | Conformationally restricted dinucleotide monomers and oligonucleotides |
| US20110319473A1 (en) * | 2010-06-29 | 2011-12-29 | Surmodics, Inc. | Compositions and methods for enhancement of nucleic acid delivery |
| US8691750B2 (en) | 2011-05-17 | 2014-04-08 | Axolabs Gmbh | Lipids and compositions for intracellular delivery of biologically active compounds |
| CN102552105B (zh) * | 2011-10-17 | 2014-04-02 | 复旦大学 | 一种级联脑部靶向药物递送系统及其制备方法和用途 |
| AU2013266238B2 (en) * | 2012-05-23 | 2017-07-27 | The Ohio State University | Lipid-coated albumin nanoparticle compositions and methods of making and method of using the same |
-
2013
- 2013-05-23 AU AU2013266238A patent/AU2013266238B2/en active Active
- 2013-05-23 EP EP13794381.7A patent/EP2852380A4/en not_active Withdrawn
- 2013-05-23 US US13/900,969 patent/US10307490B2/en active Active
- 2013-05-23 CA CA2871477A patent/CA2871477A1/en not_active Abandoned
- 2013-05-23 MX MX2014014251A patent/MX353567B/es active IP Right Grant
- 2013-05-23 CN CN201380026005.5A patent/CN104428005B/zh active Active
- 2013-05-23 CA CA2874495A patent/CA2874495A1/en not_active Abandoned
- 2013-05-23 BR BR112014027834A patent/BR112014027834A2/pt not_active Application Discontinuation
- 2013-05-23 EP EP13726404.0A patent/EP2852415A1/en not_active Withdrawn
- 2013-05-23 CN CN201380033174.1A patent/CN105163721B/zh active Active
- 2013-05-23 US US14/403,313 patent/US9750819B2/en active Active
- 2013-05-23 US US14/403,315 patent/US20160015824A1/en not_active Abandoned
- 2013-05-23 WO PCT/US2013/042454 patent/WO2013177415A1/en not_active Ceased
- 2013-05-23 MX MX2018000744A patent/MX384803B/es unknown
- 2013-05-23 KR KR1020147036015A patent/KR20150032945A/ko not_active Withdrawn
- 2013-05-23 JP JP2015514192A patent/JP2015525209A/ja active Pending
- 2013-05-23 JP JP2015514189A patent/JP6220389B2/ja not_active Expired - Fee Related
- 2013-05-23 EP EP13794027.6A patent/EP2852381B1/en active Active
- 2013-05-23 MX MX2014014196A patent/MX2014014196A/es unknown
- 2013-05-23 KR KR1020147036014A patent/KR102169891B1/ko active Active
- 2013-05-23 AU AU2013266232A patent/AU2013266232B2/en not_active Ceased
- 2013-05-23 CA CA2874490A patent/CA2874490C/en active Active
- 2013-05-23 WO PCT/US2013/042458 patent/WO2013177419A2/en not_active Ceased
- 2013-05-23 JP JP2015514193A patent/JP6228191B2/ja active Active
- 2013-05-23 KR KR1020147032915A patent/KR20150020180A/ko not_active Ceased
- 2013-05-23 AU AU2013266236A patent/AU2013266236A1/en not_active Abandoned
- 2013-05-23 BR BR112014029247A patent/BR112014029247A2/pt not_active IP Right Cessation
- 2013-05-23 CN CN201380033165.2A patent/CN104582691A/zh active Pending
- 2013-05-23 WO PCT/US2013/042461 patent/WO2013177421A2/en not_active Ceased
-
2017
- 2017-08-29 US US15/689,667 patent/US20180021447A1/en not_active Abandoned
- 2017-09-29 JP JP2017191221A patent/JP2018002727A/ja active Pending
- 2017-10-09 AU AU2017245294A patent/AU2017245294B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sun et al. | RETRACTED ARTICLE: siRNA-loaded poly (histidine-arginine) 6-modified chitosan nanoparticle with enhanced cell-penetrating and endosomal escape capacities for suppressing breast tumor metastasis | |
| Chen et al. | Exosomes as drug carriers in anti-cancer therapy | |
| Iturrioz-Rodríguez et al. | Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment | |
| Fang et al. | Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe3O4 nanoparticles for targeted drug delivery | |
| Yadav et al. | Advances in delivery of chemotherapeutic agents for cancer treatment | |
| Yang et al. | Recent advances in liposome formulations for breast cancer therapeutics | |
| Shah et al. | Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug | |
| US20250195641A1 (en) | Immunotherapeutic constructs and methods of their use | |
| Tao et al. | Angiopep-2-conjugated “core–shell” hybrid nanovehicles for targeted and pH-triggered delivery of arsenic trioxide into glioma | |
| Zheng et al. | Tumor-associated macrophages in nanomaterial-based anti-tumor therapy: as target spots or delivery platforms | |
| Wang et al. | Targeted delivery of tumor suppressor microRNA-1 by transferrin-conjugated lipopolyplex nanoparticles to patient-derived glioblastoma stem cells | |
| Karpisheh et al. | RETRACTED: Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells | |
| He et al. | Cancer cell membrane decorated silica nanoparticle loaded with miR495 and doxorubicin to overcome drug resistance for effective lung cancer therapy | |
| Jiang et al. | Targeted delivery of CXCR4-siRNA by scFv for HER2+ breast cancer therapy | |
| Patel et al. | Development of amino acid-modified biodegradable lipid nanoparticles for siRNA delivery | |
| US20250041325A1 (en) | Lipid-based compositions and methods thereof | |
| Gu et al. | Formulation/preparation of functionalized nanoparticles for in vivo targeted drug delivery | |
| Xing et al. | Janus nanocarriers for magnetically targeted and hyperthermia-enhanced curcumin therapy of liver cancer | |
| Liang et al. | Targeted-delivery of siRNA via a polypeptide-modified liposome for the treatment of gp96 over-expressed breast cancer | |
| WO2021011496A1 (en) | Immunotherapeutic constructs and methods of their use | |
| He et al. | Remodeling tumor immunosuppression with molecularly imprinted nanoparticles to enhance immunogenic cell death for cancer immunotherapy | |
| Mashreghi et al. | Anti‐epithelial cell adhesion molecule RNA aptamer‐conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model | |
| Nam et al. | Adjuvant-loaded spiky gold nanoparticles for activation of innate immune cells | |
| Duan et al. | Detachable dual-targeting nanoparticles for improving the antitumor effect by extracellular matrix depletion | |
| Du et al. | Glutamine metabolism-regulated nanoparticles to enhance chemoimmunotherapy by increasing antigen presentation efficiency |